On July 9, 2018 Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) reported that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer and Gregory Chow, Senior Vice President and Chief Financial Officer, will participate at the upcoming Oppenheimer & Co. Inc. Boston Oncology Insight Summit to be held at the Whitehead Institute on July 10, 2018 and 1×1 Day to be held at the Four Seasons Hotel on July 11, 2018 in Boston, MA (Press release, Aptose Biosciences, JUL 9, 2018, View Source;p=RssLanding&cat=news&id=2357337 [SID1234527611]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!